Affinity Asset Advisors, LLC Q4 2022 Filing
Filed February 13, 2023
Portfolio Value
$255.0T
Holdings
60
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (60 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | 290ACHINOOK THERAPEUTICS INC | 818,035 | $21.4M | 0.00% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS INC | 70,000 | $20.3M | 0.00% | |
| 3 | BMYBRISTOL MYERS SQUIBB CO | 175,000 | $12.6M | 0.00% | Put |
| 4 | ESTAESTABLISHMENT LABS HLDGS INC | 190,767 | $12.5M | 0.00% | |
| 5 | VRNAVERONA PHARMA PLC | 417,498 | $10.9M | 0.00% | Call |
| 6 | ASNDASCENDIS PHARMA A S | 70,997 | $8.7M | 0.00% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 80,000 | $8.3M | 0.00% | |
| 8 | —PROMETHEUS BIOSCIENCES INC | 75,000 | $8.3M | 0.00% | |
| 9 | VTYXVENTYX BIOSCIENCES INC | 240,623 | $7.9M | 0.00% | |
| 10 | MORFMORPHIC HLDG INC | 280,921 | $7.5M | 0.00% | |
| 11 | ACLXARCELLX INC | 240,143 | $7.4M | 0.00% | |
| 12 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,143,531 | $7.2M | 0.00% | |
| 13 | CATBUSDASTRIA THERAPEUTICS INC | 472,482 | $7.0M | 0.00% | |
| 14 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 215,000 | $6.8M | 0.00% | |
| 15 | NARIUSDINARI MED INC | 90,000 | $5.7M | 0.00% | |
| 16 | VKTXVIKING THERAPEUTICS INC | 600,000 | $5.6M | 0.00% | Call |
| 17 | MRNAMODERNA INC | 30,000 | $5.4M | 0.00% | Put |
| 18 | AMGNAMGEN INC | 20,000 | $5.3M | 0.00% | Put |
| 19 | HZNPHORIZON THERAPEUTICS PUB L | 45,000 | $5.1M | 0.00% | |
| 20 | RCKTROCKET PHARMACEUTICALS INC | 258,115 | $5.1M | 0.00% | |
| 21 | TCE2CELLDEX THERAPEUTICS INC NEW | 110,000 | $4.9M | 0.00% | |
| 22 | BLUBELLUS HEALTH INC NEW | 573,678 | $4.7M | 0.00% | |
| 23 | GONGERON CORP | 1,893,500 | $4.6M | 0.00% | Put |
| 24 | AZNASTRAZENECA PLC | 60,000 | $4.1M | 0.00% | |
| 25 | CYTKCYTOKINETICS INC | 87,601 | $4.0M | 0.00% | |
| 26 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 10,000,000 | $3.9M | 0.00% | |
| 27 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 7,500,000 | $3.4M | 0.00% | |
| 28 | KURAKURA ONCOLOGY INC | 268,747 | $3.3M | 0.00% | |
| 29 | LNTHLANTHEUS HLDGS INC | 60,630 | $3.1M | 0.00% | |
| 30 | PCVXVAXCYTE INC | 60,000 | $2.9M | 0.00% | |
| 31 | SNDXSYNDAX PHARMACEUTICALS INC | 100,000 | $2.5M | 0.00% | |
| 32 | IOVAIOVANCE BIOTHERAPEUTICS INC | 375,000 | $2.4M | 0.00% | |
| 33 | KPTIEURKARYOPHARM THERAPEUTICS INC | 661,264 | $2.2M | 0.00% | |
| 34 | COGTCOGENT BIOSCIENCES INC | 193,064 | $2.2M | 0.00% | |
| 35 | —POINT BIOPHARMA GLOBAL INC | 303,218 | $2.2M | 0.00% | |
| 36 | NVV1NOVAVAX INC | 200,000 | $2.1M | 0.00% | Put |
| 37 | XENEXENON PHARMACEUTICALS INC | 50,000 | $2.0M | 0.00% | |
| 38 | ARGXARGENX SE | 5,000 | $1.9M | 0.00% | |
| 39 | NVCRNOVOCURE LTD | 25,000 | $1.8M | 0.00% | Call |
| 40 | NVLSEURALPINE IMMUNE SCIENCES INC | 247,891 | $1.8M | 0.00% | |
| 41 | —VINCERX PHARMA INC | 1,492,771 | $1.5M | 0.00% | |
| 42 | —PRECIGEN INC | 1,500,000 | $1.5M | 0.00% | |
| 43 | CNTACENTESSA PHARMACEUTICALS PLC | 460,328 | $1.4M | 0.00% | |
| 44 | ESPR 4 11/15/25ESPERION THERAPEUTICS INC NE | 2,500,000 | $1.4M | 0.00% | |
| 45 | KALVKALVISTA PHARMACEUTICALS INC | 188,292 | $1.3M | 0.00% | |
| 46 | BCABBIOATLA INC | 150,000 | $1.2M | 0.00% | |
| 47 | DYNDYNE THERAPEUTICS INC | 92,170 | $1.1M | 0.00% | |
| 48 | LIANYLIANBIO | 650,000 | $1.1M | 0.00% | |
| 49 | NRIXNURIX THERAPEUTICS INC | 80,000 | $878K | 0.00% | |
| 50 | MIRMMIRUM PHARMACEUTICALS INC | 40,000 | $780K | 0.00% | |
| 51 | FHTXFOGHORN THERAPEUTICS INC | 109,991 | $701K | 0.00% | |
| 52 | SGENUSDSEAGEN INC | 5,000 | $642K | 0.00% | |
| 53 | CNTXCONTEXT THERAPEUTICS INC | 883,654 | $583K | 0.00% | |
| 54 | INZYINOZYME PHARMA INC | 500,000 | $525K | 0.00% | |
| 55 | NUVBNUVATION BIO INC | 250,000 | $480K | 0.00% | |
| 56 | IMTXIMMATICS N.V | 187,204 | $469K | 0.00% | |
| 57 | MISTMILESTONE PHARMACEUTICALS IN | 100,000 | $396K | 0.00% | |
| 58 | SCLXWSCILEX HOLDING CO | 18,099 | $3K | 0.00% | |
| 59 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $2K | 0.00% | |
| 60 | SCLXUSDSCILEX HOLDING CO | 463 | $1K | 0.00% |